Termination Agreement between Medicis Pharmaceutical Corporation and Michael A. Pietrangelo

Summary

Medicis Pharmaceutical Corporation and Michael A. Pietrangelo have agreed to end their previous consulting agreement, effective September 30, 2005. This termination means that both parties are released from any further rights or obligations under the original consulting arrangement. The agreement was formally executed on October 19, 2005.

EX-10.2 3 p71352exv10w2.htm EXHIBIT 10.2 exv10w2

Exhibit 10.2

TERMINATION AGREEMENT

THIS TERMINATION AGREEMENT, effective September 30, 2005, is made and entered into by and between Medicis Pharmaceutical Corporation, a Delaware corporation (“Medicis”), and Michael A. Pietrangelo.

RECITALS:

WHEREAS, the parties entered into a letter agreement, dated November 5, 1997 (the “Consulting Agreement”), regarding the provision of certain consulting services by Mr. Pietrangelo to the Company; and

WHEREAS, the parties wish to terminate the Consulting Agreement and their respective rights and obligations thereunder effective September 30, 2005.

NOW, THEREFORE, each of the Company and Mr. Pietrangelo agree that the Consulting Agreement and their respective rights and obligations thereunder shall be terminated effective September 30, 2005.

IN WITNESS WHEREOF, this Agreement has been duly executed and delivered by the parties on October 19, 2005.


	MEDICIS PHARMACEUTICAL CORPORATION
	By:	/s/ Jonah Shacknai
	Name:	Jonah Shacknai
	Title:	Chairman and Chief Executive Officer


	MICHAEL A. PIETRANGELO
	By:	/s/ Michael A. Pietrangelo
	Name:	Michael A. Pietrangelo